share_log

UPLOAD: Others

SEC announcement ·  Apr 17 01:23
Summary by Futu AI
Apollomics Inc., a biopharmaceutical company, has received a comment from the United States Securities and Exchange Commission (SEC) regarding its Registration Statement on Form F-3. The SEC's correspondence, dated April 15, 2024, is a follow-up to Apollomics' response on April 12, 2024, and requests further amendments to the registration statement. The SEC has specifically asked Apollomics to reconcile conflicting information about the residency of its board members. The company had previously indicated that all board members reside outside of China, yet the filing suggests two directors are based in mainland China. The SEC has invited Apollomics to either amend the registration statement or explain why such an amendment is not necessary. The company is expected to respond to the SEC's request, and further comments from the SEC may follow upon review of the amendments and the company's response.
Apollomics Inc., a biopharmaceutical company, has received a comment from the United States Securities and Exchange Commission (SEC) regarding its Registration Statement on Form F-3. The SEC's correspondence, dated April 15, 2024, is a follow-up to Apollomics' response on April 12, 2024, and requests further amendments to the registration statement. The SEC has specifically asked Apollomics to reconcile conflicting information about the residency of its board members. The company had previously indicated that all board members reside outside of China, yet the filing suggests two directors are based in mainland China. The SEC has invited Apollomics to either amend the registration statement or explain why such an amendment is not necessary. The company is expected to respond to the SEC's request, and further comments from the SEC may follow upon review of the amendments and the company's response.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.